SCHEMBL21477564

SCHEMBL21477564

CC(C)c1cnc2[nH]ncc2n1

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 1/20 0.36
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.31
CYP1A2 P05177 1/20 0.31
PDPK1 O15530 1/20 0.31
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
F2 P00734 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
HTT P42858 1/20 0.31
PTK2 Q05397 1/20 0.31
TRPA1 O75762 1/20 0.30
CHEK1 O14757 1/20 0.30
AURKA O14965 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18237617 0.85 ALDH1A1 (0.33) ALDH1A1MAPK1CYP1A2PDPK1KDM4E
SCHEMBL18238040 0.75 ALDH1A1 (0.33) ALDH1A1KDM4E
SCHEMBL15242452 0.74 HTT (0.38) PIK3CGALDH1A1MAPK1PDPK1KDM4E
SCHEMBL21477569 0.72
SCHEMBL2611061 0.72 MAPK1 (0.55) PIK3CGMAPK1
SCHEMBL18238450 0.72 HSD17B10 (0.33) ALDH1A1KDM4E
SCHEMBL23996471 0.69 XDH (0.32) MAPK1
SCHEMBL29912846 0.69 MAPK1 (0.52) MAPK1PTK2AURKA
SCHEMBL30696088 0.69 XDH (0.36) ALDH1A1MAPK1CYP1A2
SCHEMBL10693005 0.69 XDH (0.36) ALDH1A1MAPK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3838897-A2 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen TargetRx, Inc. (CN) 2021-06-23 EP disclosed
EP-3553056-B1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY SHENZHEN TARGETRX INC (CN) 2021-02-17 EP disclosed
EP-3553056-A1 (HETERO)ARYLAMIDE COMPOUND FOR INHIBITING PROTEIN KINASE ACTIVITY Shenzhen Targetrx, Inc. (CN) 2019-10-16 EP disclosed